Immunic Inc (IMUX)
1.25
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.25
0.00 (0.00%)
After-Hours: 20:00
Immunic Shareholders Equity (Quarterly): 83.58M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 83.58M |
| December 31, 2023 | 28.93M |
| September 30, 2023 | 48.41M |
| June 30, 2023 | 69.28M |
| March 31, 2023 | 91.22M |
| December 31, 2022 | 113.68M |
| September 30, 2022 | 108.81M |
| June 30, 2022 | 127.85M |
| March 31, 2022 | 137.96M |
| December 31, 2021 | 127.12M |
| September 30, 2021 | 145.46M |
| June 30, 2021 | 120.74M |
| March 31, 2021 | 137.45M |
| December 31, 2020 | 158.78M |
| September 30, 2020 | 162.88M |
| June 30, 2020 | 78.68M |
| March 31, 2020 | 50.49M |
| December 31, 2019 | 58.36M |
| September 30, 2019 | 60.53M |
| June 30, 2019 | 69.41M |
| March 31, 2019 | 9.049M |
| December 31, 2018 | 12.43M |
| September 30, 2018 | 14.25M |
| Date | Value |
|---|---|
| June 30, 2018 | 26.45M |
| March 31, 2018 | 37.30M |
| December 31, 2017 | 50.04M |
| September 30, 2017 | 62.08M |
| June 30, 2017 | 73.34M |
| March 31, 2017 | 84.43M |
| December 31, 2016 | 58.45M |
| September 30, 2016 | 67.76M |
| June 30, 2016 | 74.15M |
| March 31, 2016 | 78.05M |
| December 31, 2015 | 82.32M |
| September 30, 2015 | 58.68M |
| June 30, 2015 | 69.74M |
| March 31, 2015 | 83.78M |
| December 31, 2014 | 97.56M |
| September 30, 2014 | 77.05M |
| June 30, 2014 | 89.16M |
| March 31, 2014 | -58.02M |
| December 31, 2013 | -44.66M |
| September 30, 2013 | -32.88M |
| June 30, 2013 | -24.17M |
| December 31, 2012 | -7.632M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
28.93M
Minimum
Dec 2023
162.88M
Maximum
Sep 2020
98.98M
Average
100.01M
Median
Shareholders Equity (Quarterly) Benchmarks
| Kymera Therapeutics Inc | 711.20M |
| Insmed Inc | -464.81M |
| SELLAS Life Sciences Group Inc | 9.684M |
| Skye Bioscience Inc | 78.88M |
| Leap Therapeutics Inc | 47.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 104.16M |
| Total Liabilities (Quarterly) | 20.58M |